Fakes, facts, society and health
The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.
The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.
A new University of Bristol-led project aims to ease pressure on the NHS by developing an artificial intelligence (AI) model to predict and reduce a patient’s risk of readmission to hospital.
A new University of Bristol-based evidence synthesis team has been awarded £2.5 million from the National Institute for Health and Care Research (NIHR).
A leading climate scientist from the University of Bristol, has today won an award in recognition of his pioneering work to advance understanding of global weather extremes and their impact on society.
Experts are helping put the UK at the forefront of AI advances, using it to transform current uses and tackle important global challenges.
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
The UK government's levelling up agenda is set to fail in its mission to address inequalities unless it tackles the root causes of poor health, according to a new study.
The University of Bristol's Cancer Research Network hosted its second annual symposium dedicated to early career researchers. The event showcased the extraordinary and diverse research being conducted by postgraduate students, postdoctoral researchers, clinical fellows and trainees across Bristol and the South-West.
CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round.